Patent classifications
A23K10/18
Transformed, salmo salar interferon gamma (ifng)-producing lactococcus lactis bacterium, food and composition comprising same, for immunostimulation in aquaculture species
The present invention falls within the technical field of aquaculture, and specifically, the invention relates to a specific solution for preventing and treating bacterial diseases using a Lactococcus lactis lactic acid bacterium transformed to produce an interferon type II (IFN II) immunostimulating cytokine, particularly interferon gamma (IFNg or IFNγ). Said transformed bacterium has been deposited in the Chilean Microbial Genetic Resources Collection at INIA with accession number RGM 2416 dated 22 Oct. 2017. The invention is also related to an immunostimulating food for aquaculture species comprising the lactic acid bacterium transformed with IFN type II from salmonidae. Moreover, the invention relates to the method for preparing said probiotic food, the method for preparing said lactic acid bacterium expressing IFNg, in other words which produces a cytokine that stimulates the antibacterial immune response.
Pet Food Compositions Including Probiotics and Methods of Manufacture and Use Thereof
The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.
Pet Food Compositions Including Probiotics and Methods of Manufacture and Use Thereof
The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.
USE OF SOPHOROLIPIDS AS FEED ADDITIVE
The invention relates to methods for modulation of the gut flora and/or for supporting immune system function in animals comprising administration of one or more sophorolipids to an animal in need thereof. Animal feed compositions comprising sophorolipids are also provided.
USE OF SOPHOROLIPIDS AS FEED ADDITIVE
The invention relates to methods for modulation of the gut flora and/or for supporting immune system function in animals comprising administration of one or more sophorolipids to an animal in need thereof. Animal feed compositions comprising sophorolipids are also provided.
FEED ADDITIVE COMPOSITIONS
The present invention provides feed compositions comprising a basal animal diet supplemented with direct fed microbial (DFM) and at least one of a formulated yeast, a Capsicum product, and an antimicrobial clay. The feed compositions improve growth, general health, intestinal health, and reduce microbial pathogens in non-human animals fed the feed compositions.
FEED ADDITIVE COMPOSITIONS
The present invention provides feed compositions comprising a basal animal diet supplemented with direct fed microbial (DFM) and at least one of a formulated yeast, a Capsicum product, and an antimicrobial clay. The feed compositions improve growth, general health, intestinal health, and reduce microbial pathogens in non-human animals fed the feed compositions.
COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED THERETO
The disclosure relates generally to bacterial strains of the genus Christensenella, e.g., Christensenella sp. P152-H6d bacterial strains, and compositions comprising such bacterial strains. The disclosure further relates to methods of using such bacterial strains and compositions for preventing or treating a disorder, e.g, an inflammatory disorder, a gastrointestinal disorder, a metabolic disorder, and/or dysbiosis.
<i>Bacillus </i>compositions and methods of use with ruminants
Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.
<i>Bacillus </i>compositions and methods of use with ruminants
Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.